All Updates

All Updates

icon
Filter
Earnings/results
Hippo’s net losses dragged down by the impact of hurricane Ian in Q3 2022
InsurTech: Personal Lines
Nov 10, 2022
This week:
Funding
EKORE raises EUR 1.3 million (~ USD 1 million) in seed funding to strengthen platform
Digital Twin
Dec 20, 2024
Funding
Culina Health raises USD 7.9 million in Series A funding to expand offerings and expand team
Functional Nutrition
Dec 19, 2024
FDA approval
ViGeneron receives IND clearance for VG801 gene therapy
Cell & Gene Therapy
Dec 19, 2024
Product updates
Reflex Aerospace ships first commercial satellite SIGI
Next-gen Satellites
Dec 19, 2024
Partnerships
Vast partners with SpaceX for two private astronaut missions to ISS
Space Travel and Exploration Tech
Dec 19, 2024
Management news
Carbios appoints Philippe Pouletty as interim CEO amid plant delay
Waste Recovery & Management Tech
Dec 19, 2024
Funding
BlueQubit raises USD 10 million in seed funding to develop quantum platform
Quantum Computing
Dec 19, 2024
FDA approval
Arbor Biotechnologies receives FDA clearance for ABO-101 IND application
Human Gene Editing
Dec 19, 2024
Partnerships
Funding
Personalis partners with Merck and Moderna for cancer therapy development and investment
Precision Medicine
Dec 19, 2024
Partnerships
COTA partners with Guardant Health to develop clinicogenomic data solutions for cancer research
Precision Medicine
Dec 19, 2024
InsurTech: Personal Lines

InsurTech: Personal Lines

Nov 10, 2022

Hippo’s net losses dragged down by the impact of hurricane Ian in Q3 2022

Earnings/results

  • Hippo reported a net loss per share of USD 5.66 in Q3 2022, falling short of analyst estimates of a USD 2.87 loss per share. Net loss attributable to Hippo declined 318.1% YoY to USD 129.2 million compared to a loss of USD 30.9 million over the same period last year.

  • The company’s gross loss ratio improved by 18 percentage points to 110% during the quarter, compared to 128% last year. Excluding the impact of Hurricane Ian, its gross loss ratio is reported to be 58%, benefitting from its continuous improvement in re-underwriting efforts during the first half of the year.

  • Hippo’s total generated premiums (TGP; which include gross written premiums and gross placed premiums) amounted to USD 219.3 million in Q3 2022, 35.6% higher than the premiums generated over the same period last year, while net earned premiums during the quarter decreased marginally by 1.8% YoY to USD 10.7 million. 

  • The increase in TGP is primarily due to the improvement in its Builder business (insurance for newly built homes), which accounted for 26% of total Hippo and agency premiums in the quarter and nearly half of its new business. As of September 2022, Hippo had 332,000 customers and claims 75% of new customers were Gen B.

  • Hippo maintained its guidance for the full year of FY2022 and expects TGP to be in the range of USD 790 million–810 million, implying growth of 30.3%–32.6% YoY. The company also expects to achieve a gross loss ratio below 90% compared to 138% in FY2021.

  • In addition, the company expects to launch the “Book a Pro” feature within its mobile app in Q4 2022, which allows homeowners based in Texas to connect to home improvement professionals as well as message its own home care experts to get advice. It also aims to aggressively roll out this feature to other geographies. 

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.